Results 101 to 110 of about 21,804,485 (185)

Effect of permeability enhancers on paracellular permeability of acyclovir

open access: yes, 2016
Objectives According to Biopharmaceutics Classification System (BCS), acyclovir is a class III (high solubility, low permeability) compound, and it is transported through paracellular route by passive diffusion.
Ates, Muge   +2 more
core   +1 more source

The Biopharmaceutical Classification System [Bcs] and Its Relevance to Solubility Issues

open access: yes
The Biopharmaceutics Classification System (BCS) is a scientifically established framework introduced by the U.S. FDA to categorize drug substances according to their solubility and permeability properties. This system plays a vital role in drug development, especially for generic drugs, by enabling the prediction of in vivo drug performance using in ...
openaire   +2 more sources

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

BIOPHARMACEUTICS AND APPROACHES TO DRUG ABSORPTION ENHANCEMENT

open access: yes
Biopharmaceutics is a foundational discipline in pharmaceutical sciences that focuses on the interplay between drug physicochemical properties, formulation design, and physiological factors governing drug absorption and bioavailability.
Shradha. S. Mathpati   +4 more
core   +1 more source

Drug Delivery and Repurposing Approaches for Albendazole Formulations

open access: yesBIO Integration
According to World Health Organization (WHO) reports, parasitic infections substantially affect the world’s population and are responsible for more than 16 million annual deaths in developing countries.
Shachi Virlley   +8 more
doaj   +1 more source

Resolving the Conflict between BCS and BDDCS for the Advancement of the Drug Discovery, Development, and Regulatory Processes [PDF]

open access: yes, 2014
Drug permeability is accepted as a screening tool for determining intestinal absorption via the Biopharmaceutics Classification System (BCS) during the drug development and regulatory approval processes. Currently, predicting clinically significant drug
Larregieu, Caroline A.
core  

Intrinsic Dissolution as a Tool for Evaluating Drug Solubility in Accordance with the Biopharmaceutics Classification System

open access: yes, 2011
The Biopharmaceutics Classification System (BCS) is a tool that was created to categorize drugs into different groups according to their solubility and permeability characteristics.
ISSA, Michele G., FERRAZ, Humberto G.
core   +1 more source

Biowaiver Based on the Biopharmaceutical Classification System: Regulatory Basis and Limits of Scientific Interpretation (Review)

open access: yesРегуляторные исследования и экспертиза лекарственных средств
INRODUCTION. Biowaiver procedure based on the biopharmaceutics classification system (BCS) is widely used in regulatory practice when assessing the bioequivalence of generic medicinal products (GMPs).
N. J. Dahma   +5 more
doaj   +1 more source

Optimizing Paclitaxel Oral Absorption and Bioavailability: TPGS Co-Coating via Supercritical Anti-Solvent Fluidized Bed Technology

open access: yesPharmaceuticals
Supercritical anti-solvent fluidized bed (SAS-FB) coating technology has the advantages of reducing particle size, preventing high surface energy particle aggregation, improving the dissolution performance and bioavailability of insoluble drugs. The poor
Zicheng Zhong   +12 more
doaj   +1 more source

Biowaiver as a Bioequivalence Study Option

open access: yesРегуляторные исследования и экспертиза лекарственных средств
SCIENTIFIC RELEVANCE. Biowaiver is a procedure for establishing the bioequivalence of generic and reference products without in vivo studies. Regulatory requirements for this procedure, as described in a variety of documents, differ in certain features ...
E. A. Volkova   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy